Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation

NCT01848743 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Chronic HBV With Severe Exacerbation

Interventions

DRUG: Tenofovir
DRUG: lamivudine

Sponsor

Kaohsiung Veterans General Hospital.